IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 366 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354,489 | -6.7% | 7,815 | -15.6% | 0.00% | – |
| Q2 2023 | $379,938 | +19.2% | 9,260 | +3.8% | 0.00% | – |
| Q1 2023 | $318,694 | -36.4% | 8,917 | -33.1% | 0.00% | – |
| Q4 2022 | $501,000 | -70.7% | 13,331 | -65.6% | 0.00% | -100.0% |
| Q3 2022 | $1,711,000 | +306.4% | 38,703 | +240.0% | 0.00% | – |
| Q2 2022 | $421,000 | -9.9% | 11,384 | -10.2% | 0.00% | – |
| Q1 2022 | $467,000 | +59.4% | 12,682 | +31.7% | 0.00% | – |
| Q4 2021 | $293,000 | -19.9% | 9,627 | -11.7% | 0.00% | – |
| Q3 2021 | $366,000 | -7.3% | 10,899 | +9.8% | 0.00% | – |
| Q2 2021 | $395,000 | -39.4% | 9,925 | -31.4% | 0.00% | – |
| Q1 2021 | $652,000 | -24.6% | 14,478 | -5.1% | 0.00% | – |
| Q4 2020 | $865,000 | +73.7% | 15,259 | +45.2% | 0.00% | – |
| Q3 2020 | $498,000 | -23.7% | 10,512 | -4.9% | 0.00% | – |
| Q2 2020 | $653,000 | +38.3% | 11,058 | +11.0% | 0.00% | – |
| Q1 2020 | $472,000 | -16.2% | 9,960 | +7.0% | 0.00% | – |
| Q4 2019 | $563,000 | +14.9% | 9,305 | +13.5% | 0.00% | – |
| Q3 2019 | $490,000 | -3.2% | 8,197 | +4.2% | 0.00% | – |
| Q2 2019 | $506,000 | -34.0% | 7,868 | -16.8% | 0.00% | – |
| Q1 2019 | $767,000 | +54.3% | 9,454 | +3.0% | 0.00% | – |
| Q4 2018 | $497,000 | -28.2% | 9,183 | -31.5% | 0.00% | – |
| Q3 2018 | $692,000 | -88.6% | 13,406 | -90.8% | 0.00% | -100.0% |
| Q2 2018 | $6,053,000 | +88.1% | 145,296 | +99.0% | 0.00% | +200.0% |
| Q1 2018 | $3,218,000 | +227.4% | 73,025 | +273.8% | 0.00% | – |
| Q4 2017 | $983,000 | +115.6% | 19,535 | +117.6% | 0.00% | – |
| Q3 2017 | $456,000 | -52.2% | 8,978 | -52.1% | 0.00% | – |
| Q2 2017 | $953,000 | +364.9% | 18,752 | +267.3% | 0.00% | – |
| Q1 2017 | $205,000 | -72.0% | 5,105 | -66.6% | 0.00% | – |
| Q4 2016 | $731,000 | -76.8% | 15,287 | -70.0% | 0.00% | -100.0% |
| Q4 2015 | $3,156,000 | – | 50,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |